The ROE as of November 2024 (TTM) for Akari Therapeutics, Plc (AKTX) is 550.78%

According to Akari Therapeutics, Plc’s latest financial reports and current stock price. The company's current ROE is 550.78%. This represents a change of 13.89% compared to the average of 483.61% of the last 4 quarters.

Akari Therapeutics, Plc (AKTX) Historical ROE (quarterly & annually)

How has AKTX ROE performed in the past?

The mean historical ROE of Akari Therapeutics, Plc over the last ten years is 232.05%. The current 550.78% ROE has changed 137.35% with respect to the historical average. Over the past ten years (40 quarters), AKTX's ROE was at its highest in in the September 2023 quarter at 1.53%. The ROE was at its lowest in in the June 2021 quarter at -275.53%.

Akari Therapeutics, Plc (AKTX) ROE by Quarter and Year

Discovering the peaks and valleys of Akari Therapeutics, Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akari Therapeutics, Plc (AKTX) Average ROE

How has AKTX ROE performed in the past?

The current ROE of Akari Therapeutics, Plc (AKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Akari Therapeutics, Plc (AKTX) ROE vs. Peers

How is AKTX’s ROE compared to its peers?

Akari Therapeutics, Plc’s ROE is less than Armata Pharmaceuticals, Inc. (89.12%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Scopus BioPharma Inc. (911.69%), greater than Processa Pharmaceuticals, Inc. (-195.22%), less than Salarius Pharmaceuticals, Inc. (0%), greater than Axcella Health Inc. (-140.30%), greater than Magenta Therapeutics, Inc. (-620.40%), greater than Histogen Inc. (-14.27%), greater than Pulmatrix, Inc. (-80.69%), greater than Capricor Therapeutics, Inc. (-63.07%), greater than Diffusion Pharmaceuticals Inc. (-41648.68%), greater than Soleno Therapeutics, Inc. (0.31%), greater than Oncorus, Inc. (-61.99%), greater than Sonnet BioTherapeutics Holdings, Inc. (-82.19%), greater than Landos Biopharma, Inc. (-398.33%), greater than null (-73.00%),

Build a custom stock screener for Akari Therapeutics, Plc (AKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akari Therapeutics, Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akari Therapeutics, Plc (AKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akari Therapeutics, Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.